Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Medidata Solutions

Founders Glen de Vries

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$21M
Portfolio companies 5
Rounds per year 0.25
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Exits 1
Key employees 1

Areas of investment

  • Health Care
  • Analytics
  • Pharmaceutical
  • Life Science
  • Information Services
Summary

Medidata Solutions appeared to be the Corporate Investor, which was created in 1999. The main department of described Corporate Investor is located in the New York. The venture was found in North America in United States.

Considering the real fund results, this Corporate Investor is 5 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2017. The higher amount of exits for fund were in 2018. This Medidata Solutions works on 21 percentage points more the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year.

The current fund was established by Glen de Vries.

Among the most successful fund investment fields, there are Semantic Search, Health Care. Among the various public portfolio startups of the fund, we may underline Medidata Solutions, Syapse, Shyft Besides, a startup needs to be aged 2-3 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Medidata Solutions, startups are often financed by Social Capital, Safeguard Scientifics, Health Enterprise Partners. The meaningful sponsors for the fund in investment in the same round are Social Capital, Silicon Alley Venture Partners, Safeguard Scientifics. In the next rounds fund is usually obtained by Optum Ventures, McKesson, Insight Partners.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Medidata Solutions:
Typical Co-investors
Medidata Solutions is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Medidata Solutions:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
32 Equity New York, New York, United States
A.L. Mailman Foundation -
alumshares North Carolina, Raleigh, United States
Fernbrook Capital Management LLC New York, New York, United States
Greentree Investment Comany -
International Private Bank (IPB) -
Journey Ventures Israel, Tel Aviv, Tel Aviv District
Markel Digital Investments -
Ronggong Touzi China, Shanghai
S&G Investment China, Shanghai
Sova VC England, London, United Kingdom
Stream Hill Angels Beijing, Beijing, China
Tako Ventures California, San Francisco, United States
The North Highland Company Atlanta, Georgia, United States
Threadless Chicago, Illinois, United States
TransLink British Columbia, Burnaby, Canada
TudorVentures -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

AllStripes

Health Care
Medical
$50M24 Aug 2021 San Francisco, California, United States

SHYFT

Analytics
Health Care
Life Science
Pharmaceutical
$7M29 Mar 2017 Massachusetts, United States

SHYFT

Analytics
Health Care
Life Science
Pharmaceutical
$12M30 Aug 2016 Massachusetts, United States
News
AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research

– AllStripes, a healthcare technology company dedicated to unlocking treatments for people affected by rare diseases, announced the closing of a $50 million Series B financing round.
– The financing was led by Lux Capital, a current investor, joined by JAZZ Venture Partners, Spark Capital, Medidata Solutions (a Dassault Systèmes company), McKesson Ventures, and Maveron, along with angel investors including Arif Nathoo, CEO of Komodo Health, and Leila Zegna, Director of the Kabuki Syndrome Foundation.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Medidata Solutions?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 6
Average round size 21M
Rounds per year 0.25
Peak activity year 2017
Lead investments 1
Follow on index 0.17
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

AllStripes

Health Care
Medical
$50M24 Aug 2021 San Francisco, California, United States

SHYFT

Analytics
Health Care
Life Science
Pharmaceutical
$7M29 Mar 2017 Massachusetts, United States

SHYFT

Analytics
Health Care
Life Science
Pharmaceutical
$12M30 Aug 2016 Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: